Baxter International

Health Care Health Care Equipment Deerfield, Illinois Last filing Feb 12, 2026 · FY2025

                    Revenue
                    FY2025
                
$11.2B
                    3y CAGR +3.8%
                    
                    P42
                    
                    n/a
                    
                    Net income
                    FY2025
                
$-957.0M
                    Net margin -8.5%
                    
                    P5
                    
                    n/a
                    
                    Total assets
                    FY2025
                
$20.1B
                    ROA -4.8%
                    
                    P7
                    
                    n/a
                    
                    Operating cash flow
                    FY2025
                
$845.0M
                    
                    n/a

19 yrs · FY2007–FY2025 9 filed · 0 derived · 0 blank

1Y 3Y 5Y 10Y

Dollars % of revenue % of assets YoY % CAGR

Each cell as a share of that year’s revenue.

Balance Sheet

Assets, liabilities, and equity

29 accounts · 1 year

Total assets $20.1B

Total liabilities $14.0B

Shareholders equity $6.1B

Account	2025	Trend
Assets
Cash and Cash Equivalents	17.5%
Short Term Investments	0.1%
Accounts Receivable	16.6%
Inventory	19.9%
Prepaid Expenses	7.2%
Total Current Assets	61.1%
Property,Plant and Equipment	25.9%
Operating Lease Assets	2.5%
Goodwill	43.8%
Intangible Assets	38.9%
Other Noncurrent Assets	6.2%
Total Assets	178.4%
Liabilities
Accounts Payable	8.9%
Accrued Liabilities	17.5%
Current Portion of Long Term Debt	0.0%
Other Current Liabilities	11.4%
Total Current Liabilities	26.4%
Operating Lease Liabilities Noncurrent	2.0%
Other Noncurrent Liabilities	11.4%
Total Liabilities	124.1%
Equity
Preferred Stock	0.0%
Common Stock	6.1%
Additional Paid In Capital	56.6%
Retained Earnings	121.9%
Treasury Stock	96.7%
Accumulated Other Comprehensive Income	-33.4%
Noncontrolling Interest	-0.2%
Total Stockholders Equity	54.5%
Total Liabilitiesand Equity	178.4%

Income Statement

Revenue, expense, and profitability

20 accounts · 1 year

Revenue $11.2B

Operating income $-308.0M

Net income $-957.0M

Account	2025	Trend
IncomeStatement
Revenues Total Revenue	100.0%
Expenses Cost of Revenue	69.9%
Expenses Research and Development	4.6%
Expenses Selling,General and Administrative	25.7%
Expenses Depreciation and Amortization	8.7%
Expenses Share Based Compensation	1.0%
Expenses Restructuring and Asset Impairment	1.4%
Other Income Expense Gross Profit	30.1%
Other Income Expense Operating Income	-2.7%
Other Income Expense Interest Income	0.5%
Other Income Expense Interest Expense	2.6%
Other Income Expense Other Income/expense	0.4%
Other Income Expense Income Before Tax	-4.5%
Income Tax Income Tax Expense	3.5%
net Income net Income	-8.5%
net Income Comprehensive Income	-6.2%
Earnings Per Share Basic Eps	-0.0%
Earnings Per Share Diluted Eps	-0.0%
Earnings Per Share Weighted Average Shares Basic	4.6%
Earnings Per Share Weighted Average Shares Diluted	4.6%

Cash Flow Statement

Operating, investing, and financing flows

20 accounts · 1 year

Operating cash flow $845.0M

Investing cash flow $2.8B

Financing cash flow $-4.2B

Account	2025	Trend
CashFlow
Operating Activities net Income	-8.5%
Operating Activities Depreciation and Amortization	3.4%
Operating Activities Stock Based Compensation	1.0%
Operating Activities Deferred Income Taxes	0.7%
Operating Activities Changes In Operating Assets and Liabilities	1.6%
Operating Activities Other Non Cash Items	-0.7%
Operating Activities net Cash From Operating Activities	7.5%
Investing Activities Business Acquisitions	0.1%
Investing Activities Proceeds From Sale of Investments	0.0%
Investing Activities Other Investing Activities	-0.5%
Investing Activities net Cash From Investing Activities	25.3%
Financing Activities Proceeds From Debt	17.8%
Financing Activities Repayment of Debt	48.8%
Financing Activities Dividends Paid	3.1%
Financing Activities Proceeds From Stock Issuance	0.3%
Financing Activities Other Financing Activities	-0.5%
Financing Activities net Cash From Financing Activities	-37.5%
Cash Reconciliation net Change In Cash	-4.0%
Cash Reconciliation Cash At Beginning of Period	17.5%
Cash Reconciliation Cash At End of Period	17.5%

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 1 year

Ratio	2025
Profitability
Gross margin	+30.1%
Operating margin	-2.7%
Net margin	-8.5%
FCF margin	—
Growth
Revenue CAGR (3y)	+3.8%
Returns
ROE	-15.6%
ROA	-4.8%
ROIC	-7.4%
Liquidity
Current ratio	2.31x
Quick ratio	1.29x
Leverage
D/E	2.28x
Interest coverage	-1.06x
Efficiency
Asset turnover	0.56x
Cash conversion cycle	+118d

Valuation

Price against fundamentals

FY2025 fundamentals · no price

No price data cached, so there is nothing to multiply. Load prices from the Stock Data tab and this panel reprices itself.

Notes

Your annotations

Not watched

Baxter International

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Assets, liabilities, and equity

Revenue, expense, and profitability

Operating, investing, and financing flows

Margins, returns, liquidity, leverage, efficiency

Price against fundamentals

Your annotations

One-year price and volume history

Price data unavailable

Recent price history